Literature DB >> 2554116

Direct inhibition of inositol-1,4,5-trisphosphate-induced Ca2+ release from brain microsomes by K+ channel blockers.

P Palade1, C Dettbarn, P Volpe, B Alderson, A S Otero.   

Abstract

Tetraethylammonium and 9-tetraethylammonium have previously been reported to inhibit inositol-1,4,5-trisphosphate (IP3)-induced Ca2+ release from brain microsomes, purportedly by blocking potassium channels [Biochem. J. 258:617-620 (1988)]. The effects of these and other K+ channel blockers have been studied here in greater detail using a spectrophotometric assay for Ca2+ movements into and out of canine brain microsomes. IP3-induced Ca2+ release was inhibited by substitution of K+ in the medium with nominally impermeant cations or by addition of most of the K+ channel blockers tested. Nevertheless, addition of valinomycin to the medium (to provide an alternative pathway for counter-ion K+ movements) failed to alleviate the inhibition of IP3-induced Ca2+ release caused by K+ channel blockers. To determine whether these substances act by inhibition of IP3 binding or by direct interaction with the Ca2+ channel of the internal store that promotes IP3-induced Ca2+ release, their effect on [3H]IP3 binding was investigated. None of the K+ channel blockers tested inhibited [3H]IP3 binding. Nearly all the K+ channel blockers appear to interact directly with a Ca2+ channel of the intracellular stores or perhaps interfere with its coupling to the IP3 receptor. Because of their multiplicity of actions, these substances cannot be presumed to be either selective K+ channel blockers or selective inhibitors of IP3-induced Ca2+ release from internal stores. Three of them were even found to partially inhibit valinomycin-stimulated 86Rb uptake into liposomes.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2554116

Source DB:  PubMed          Journal:  Mol Pharmacol        ISSN: 0026-895X            Impact factor:   4.436


  11 in total

1.  Regulation of the cerebellar inositol 1,4,5-trisphosphate receptor by univalent cations.

Authors:  Jean-François Coquil; Samantha Blazquez; Sabrina Soave; Jean-Pierre Mauger
Journal:  Biochem J       Date:  2004-07-15       Impact factor: 3.857

Review 2.  Protein-protein interactions in intracellular Ca2+-release channel function.

Authors:  J J MacKrill
Journal:  Biochem J       Date:  1999-02-01       Impact factor: 3.857

3.  Stereospecific inositol 1,4,5-[32P]trisphosphate binding to isolated rat liver nuclei: evidence for inositol trisphosphate receptor-mediated calcium release from the nucleus.

Authors:  A N Malviya; P Rogue; G Vincendon
Journal:  Proc Natl Acad Sci U S A       Date:  1990-12       Impact factor: 11.205

4.  Luminal Ca2+ increases the affinity of inositol 1,4,5-trisphosphate for its receptor.

Authors:  K A Oldershaw; C W Taylor
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

5.  Effects of lemakalim on changes in Ca2+ concentration and mechanical activity induced by noradrenaline in the rabbit mesenteric artery.

Authors:  S Ito; J Kajikuri; T Itoh; H Kuriyama
Journal:  Br J Pharmacol       Date:  1991-09       Impact factor: 8.739

6.  Tetraethylammonium blocks muscarinically evoked secretion in the sheep parotid gland by a mechanism additional to its blockade of BK channels.

Authors:  D I Cook; E A Wegman; T Ishikawa; P Poronnik; D G Allen; J A Young
Journal:  Pflugers Arch       Date:  1992-02       Impact factor: 3.657

7.  Activation of potassium channels: relationship to the heat shock response.

Authors:  A H Saad; G M Hahn
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

8.  Tetrahexylammonium ions increase Ca2+ sensitivity of contraction of guinea-pig ileal smooth muscle.

Authors:  Y Uyama; K Muraki; M P Walsh; Y Imaizumi; M Watanabe
Journal:  Pflugers Arch       Date:  1994-03       Impact factor: 3.657

9.  Ca2+ release by inositol 1,4,5-trisphosphate is blocked by the K(+)-channel blockers apamin and tetrapentylammonium ion, and a monoclonal antibody to a 63 kDa membrane protein: reversal of blockade by K+ ionophores nigericin and valinomycin and purification of the 63 kDa antibody-binding protein.

Authors:  F O'Rourke; K Soons; R Flaumenhauft; J Watras; C Baio-Larue; E Matthews; M B Feinstein
Journal:  Biochem J       Date:  1994-06-15       Impact factor: 3.857

Review 10.  Inhibitors of connexin and pannexin channels as potential therapeutics.

Authors:  Joost Willebrords; Michaël Maes; Sara Crespo Yanguas; Mathieu Vinken
Journal:  Pharmacol Ther       Date:  2017-07-15       Impact factor: 12.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.